Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 12Observational 2

Sponsor

Cancer Type

Endocrine 1Breast 1

Conditions

Breast Neoplasms 18Obesity 2Neoplasm Metastasis 2Vitamin D Deficiency 1Sleep Wake Disorders 1Recurrence 1Precancerous Conditions 1Nutrition Disorders 1Neoplasms 1Muscle Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hot Flashes 1Hormone-receptor-positive Breast Cancer 1Endometrial Neoplasms 1Depression 1Chronic Pain 1Carcinoma, Intraductal, Noninfiltrating 1Breast Cancer Organoids 1Arthralgia 1

Interventions

Blood Specimen Collection 7Drug Therapy 6Surveys and Questionnaires 5Radiotherapy 5Radiosurgery 5Docetaxel 5Therapeutics 4Specimen Handling 4Immunotherapy 4Hepatectomy 4exemestane 3enzalutamide 3apalutamide 3Trastuzumab 3Hematologic Tests 3Data Collection 3Biopsy 3Biological Assay 3Anastrozole 3Abiraterone Acetate 3trastuzumab deruxtecan 2palbociclib 2darolutamide 2abiraterone 2abemaciclib 2Wearable Electronic Devices 2Triptorelin Pamoate 2Tamoxifen 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Neoplasm Metastasis × Tamoxifen × Clear all
NCT02753686 2023-02-15

Treat ER+ight

Novartis

Completed
440 enrolled
Endocrine

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

First Hospital of China Medical University

Unknown
1,354 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡